Lexaria Bioscience LEXX
NASDAQ LEXX
$3.16 +0.03 (+0.96%)
As of: Sep 30, 2026 · 10:25 AM EDT

Lexaria Bioscience (LEXX) Work In Process (2018 - 2019)

Updated

Lexaria Bioscience (LEXX) recorded Work In Process of $25,928 in fiscal Q2 2019 (quarter ended Feb 28, 2019).

Analysis

Lexaria Bioscience (LEXX) Work In Process (2018 - 2019) Analysis & Trends

At the end of FY2018 (ended Aug 31, 2018), Lexaria Bioscience reported Work In Process of $48,126.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Lexaria Bioscience 3.39 Mn -12.26 Mn -
Historic Data

Historic Data

Download Data
DateValue
Feb 28, 2019 25,928.00
Aug 31, 2018 48,126.00
API Access

Lexaria Bioscience Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=LEXX&period=max&api_key=YOUR_API_KEY